Literature DB >> 1574552

Depressive symptomatology and cognitive functioning: an epidemiological survey in an elderly community sample in France.

R Fuhrer1, T C Antonucci, M Gagnon, J F Dartigues, P Barberger-Gateau, A Alperovitch.   

Abstract

As part of a 5-year, prospective, epidemiological survey of normal and pathological ageing, this cross-sectional analysis examines the relationship between depressive symptomatology (CES-D) and cognitive functioning (MMS) in a community sample of 2792 non-institutionalized persons (age greater than or equal to 65) living in Southwest France. Of the sample, 13.4%, report depressive symptoms above the cut-off. A significant association was found between CES-D and MMS scores, but after adjusting for age, living arrangements, and especially functional limitations, the relationship remained strong only for women.

Entities:  

Mesh：

Year:  1992        PMID： 1574552     DOI： 10.1017/s0033291700032815

Source DB:  PubMed          Journal:  Psychol Med        ISSN： 0033-2917            Impact factor:   7.723


  19 in total

1.  The PREMAP Study: prevalence and risk factors of dementia and clinically diagnosed Alzheimer's disease in Provence, France. Prevalence of Alzheimer's Disease in Provence.

Authors:  Y Obadia; M Rotily; A Degrand-Guillaud; J Guelain; M Ceccaldi; C Severo; M Poncet; A Alperovitch
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

2.  Why Is Later Age at Retirement Beneficial for Cognition? Results from a French Population-based Study.

Authors:  C Grotz; C Meillon; H Amieva; Y Stern; J-F Dartigues; S Adam; L Letenneur
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 3.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

4.  Sex Differences in the Relationship between Depressive Symptoms and Risk of Amnestic Mild Cognitive Impairment.

Authors:  Erin E Sundermann; Mindy J Katz; Richard B Lipton
Journal:  Am J Geriatr Psychiatry       Date:  2016-09-09       Impact factor: 4.105

5.  Factors associated with low cognitive performance in general practice.

Authors:  M J Dealberto; B Sauron; C Derouesné; P Boyer; D Mayeux; F Piette; F Kohler; S Lubin; A Alpérovitch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

6.  Depression is more strongly associated with cognition in elderly women than men with type 2 diabetes.

Authors:  Laili Soleimani; Ramit Ravona-Springer; Anthony Heymann; Elizabeth Guerrero-Berroa; James Schmeidler; Ruth Zukran; Rachel Preiss; Jeremy M Silverman; Mary Sano; Michal Schnaider Beeri
Journal:  Int Psychogeriatr       Date:  2018-12-11       Impact factor: 3.878

7.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis.

Authors:  Raymond L Ownby; Elizabeth Crocco; Amarilis Acevedo; Vineeth John; David Loewenstein
Journal:  Arch Gen Psychiatry       Date:  2006-05

Review 8.  The epidemiology of depressive states in the elderly: implications for recognition, intervention and prevention.

Authors:  A F Jorm
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-03       Impact factor: 4.328

Review 9.  A critical review of dimension-specific measures of health-related quality of life in cross-cultural research.

Authors:  M J Naughton; I Wiklund
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

10.  The co-occurrence of depressive symptoms and cognitive impairment in a French community: are there gender differences.

Authors:  R Fuhrer; T C Antonucci; J F Dartigues
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.